You searched for "Cybersight"

207 results found

A guide to utilising your time efficiently to develop clinical and procedural skills as an aspiring ophthalmologist

Ophthalmology often receives limited coverage in the undergraduate medical curriculum, and the availability of foundation programme jobs in this field is also restricted, reducing exposure to this field for aspiring ophthalmologists. Even if you’re not planning to specialise in ophthalmology,...

Initiatives in macular service provision

A report from Monitor in October 2015 identifies good practices that will realise most of the potential productivity gain in elective care available to NHS hospitals. These include: stratifying patients by risk and creating low-complexity pathways for lower-risk patients (tailoring...

Eye Capacity: clinical need should drive ophthalmic service provision

Almost two million people in the UK suffer sight loss, a number forecast to double over coming decades. Major causes of blindness are age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, cataract and uncorrected refractive error. Prevalence of these sight-threatening conditions...

Optical practices in England need "financial lifeline"

NHS England’s failure to act is forcing hundreds of optical practices to close, with a direct and dangerous impact on the eye healthcare of patients in England during the COVID-19 crisis, the Optical Fees Negotiating Committee (OFNC) has warned.

Land Ahoy! An interview with Geoff Hilton-Barber

It was during a previous interview with Miles Hilton-Barber [1] that I discovered that his older brother, Geoff, had been an inspiration to him. He informed me that Geoff was also blind from retinitis pigmentosa (RP) and had built his...

Flashes and floaters in community optometry – diagnosing a posterior vitreous detachment

Managing patients who attend a practice with symptoms of flashes and floaters is a regular occurrence in community optometric practice. It’s often very distressing for patients; symptoms can be quite dramatic and an internet search can indicate imminent blindness from...

Artificial intelligence and the 2024 Esme’s Umbrella Medical Student Essay Prize

Esme’s Umbrella is a charity for people with Charles Bonnet syndrome (CBS), helping raise awareness of the condition as well as offering support and advice. All clinical specialties may encounter CBS, so Esme’s Umbrella inaugurated a medical student essay prize...

Effective treatment for rare sight-threatening infection

A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.

Daughter runs half marathon to thank charity for helping save her veteran dad’s life

James Oddie, 52, from Dalkeith, a former RAF air traffic control assistant, saw his life change overnight when a brain haemorrhage and stroke left him with sight loss, double vision and severe balance issues. After returning home from hospital, everyday...

IN FOCUS - Prevention and treatment of blindness worldwide: the story of ‘VISION 2020: The Right to Sight’

The story of blindness and efforts to prevent and treat it cannot be told without going back to the earliest recorded history of blindness. Trachoma was described in ancient Egypt, cataract surgery in India about the fifth century BC and...

Decontamination and sterilisation of surgical instruments and medical devices

Ann-Marie Ablett is a Theatre Nurse and Team Leader who volunteers with Orbis. This has allowed her to gain a wealth of experience on ophthalmic procedures, nursing in under-privileged parts of the world, leadership, management and use of scarce resources....

Recurrent corneal erosions secondary to isotretinoin use

Isotretinoin (13–cis-retinoic acid) is the first line treatment for moderate to severe nodulocystic or papulopustular acne [1,2]. Although it is a safe medication, it has several adverse side-effects, including ophthalmic manifestations, as shown in Table 1 [3]. These side-effects need...